Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis

Multiple Sclerosis

Volumn 3, Issue 1, 1997, Pages 8-17

  Schiepers, Christiaan ^a   Van Hecke, Paul ^a   Vandenberghe, Rik ^a   Van Oostende, Sylvie ^a   Dupont, Patrick ^a   Demaerel, Philippe ^a   Bormans, Guy ^a   Carton, Herwig ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

FDG; Magnetic resonance imaging; Multiple sclerosis; NMR spectroscopy; Positron emission tomography; White matter

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; FEMALE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

EID: 0030978938     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300102     Document Type: Article

References (36)

1. Allen I. (1991) Pathology of multiple sclerosis, In: Matthews, ed. McAlpine's Multiple Sclerosis, Edinburgh, pp 341-378.
2. Paty DW, Li DKB, Koopmans R. (1992) MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol NeuroSurg Psy 55: 978.
3. Miller DH, McDonald WI. (1994) Neuroimaging in multiple sclerosis. Clinical Neuroscience 2: 215-224.
4. Barkhof F et al. (1992) Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity Amer J Radiol 159: 1041-1047.
5. Van Hecke P et al. (1991) Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med 18: 199-206.
6. Filippi M et al. (1995) A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand 91: 231-233.
7. Ernst T, Kreis R, Ross B. (1992) Absolute quantification of water and metabolites in the human brain. I. Compartments and water. J Magn Reson B102: 1-8.
8. Michaelis T et al. (1993) Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton NMR spectra. Radiology 187: 219-227.
9. Woods RP, Mazziotta JC, Cherry SR. (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr 17: 536-546.
10. Phelps ME et al. (1979) Tomographic measurements of local cerebral glucose metabolic rate in humans with (F-18)-fluoro-2-deoxy-glucose: validation of the method. Ann Neurol 6: 371-388.
11. Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13: 227-231.
12. Mazziotta JC, Phelps ME. (1986) Positron emission tomography studies of the brain. In: Phelps ME, Mazziotta JC, Schelbert HR, (eds) Positron emission tomography and autoradiography: principal applications for the brain and the heart. Raven Press: New York, pp 493-580.
13. Heiss WD et al. (1982) Atlas of positron emission tomography of the brain. Heidelberg, Germany, Springer Verlag, pp 47-91.
14. Wang GJ et al. (1994) Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med 35: 1457-1466.
15. Loessner A et al. (1995) Regional cerebral function determined by FDG PET in healthy volunteers: normal patterns and changes with age. J Nucl Med 36: 1141-1149.
16. Martinelli V et al. (1990) Cognitive impairment in multiple sclerosis: correlations between neuropsychological tests, brain MRI, long latency SEP's and PET. Riv Neurobiol 36: 551-557.
17. Pozzilli C et al. (1991) SPECT, MRI and cognitive functions in multiple sclerosis. J Neurol Neurosurg and Psychiat 54: 110-115.
18. Lycke J et al. (1993) Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with Tc-99m HMPAO. Eur Neurol 33:163-167
19. Larson SM. (1994) Cancer or inflammation? A holy Grail for nuclear medicine. J Nucl Med 35: 1653-1655 (Editorial).
20. Kubota R et al. (1992) Intra-tumoral distribution of F-18-Fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980.
21. Kolmel HW, Von Maravic M. (1988) Correlation of lactic acid level, cell count and cytology in cerebrospinal fluid of patients with bacterial and non-bacterial meningitis. Acta Neurol Scand 78: 6-9.
22. Miller DH, Barkhof F, Nauta JJP. (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 116: 1077-1094.
23. Minderhoud JM et al (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49: 161-165.
24. 1H spectroscopic imaging. Ann Neural 36: 157-165.
25. 1H-MRS using water as an internal standard. Magn Reson Imaging 11: 107-118.
26. Larsson HBW, Frederiksen LK, Henriksen O, Olesen J. (1988) In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 25: 743-755.
27. Tourtellotte WW, Parker JA. (1968) Some spaces and barriers in postmortem multiple sclerosis. In: Progress in Brain Research, vol 29, Lajtha A, Ford DH, (eds) Elsevier: Amsterdam, pp 493-525.
28. MacKay A et al. (1994) In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31: 673-677.
29. Arnold DL et al. (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36: 76-82.
30. Hiehle JF et al. (1994) Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med 32: 32: 285-293.
31. Bruhn H et al. (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 32: 140-150.
32. Grossman RI et al. (1992) MR proton spectroscopy in multiple sclerosis. AJNR 13: 1535-1543.
33. Matthews PM, Francis G, Antel J, Arnold DL. (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 41: 1251-1256.
34. Davie CA, Hawkins CP, Barker GJ. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117: 49-58.
35. Koopmans RA et al. (1993) Magnetic resonance spectroscopy of multiple sclerosis: In vivo detection of myelin breakdown product. Lancet 341: 631-632.
36. Van Hecke P et al. (1991) Localized brain proton MS spectroscopy of chronic MS patients. European Congress of Radiology S1226.